Dolby Laboratories
DLB Industrials Specialty Business Services
Dolby Laboratories' revenue for fiscal 2025 (year ended September 2025) was $1.3 billion, up 5.92% from fiscal 2024.
- Revenue
- −3.34%
- EPS
- −37.5%
- Free cash flow
- +157.4%
Quarter to June 2026, against a year earlier
Follow DLB
Alert me
Dolby Laboratories (DLB) P/E ratio
As of 5 November 2026, Dolby Laboratories (DLB) trades at a P/E ratio of 27.2×. Over the past ten years it has ranged from 17.5× (August 2015) to 178× (August 2018); the current reading is higher than 39% of that period. That is above the Specialty Business Services industry median of 24.5× and above the Industrials sector median of 23.3×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 27.2× | (2.95%) |
| FY2024 | 28.0× | (27.05%) |
| FY2023 | 38.4× | 8.53% |
| FY2022 | 35.4× | 23.52% |
| FY2021 | 28.7× | (0.10%) |
| FY2020 | 28.7× | 11.41% |
| FY2019 | 25.8× | (82.93%) |
| FY2018 | 151× | 418.75% |
| FY2017 | 29.1× | (0.92%) |
| FY2016 | 29.3× | 58.43% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 22.1× | (5.83%) |
| Mar 2026 | 23.5× | (8.30%) |
| Dec 2025 | 25.6× | (5.96%) |
| Sep 2025 | 27.2× | 0.75% |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| MMS Maximus, Inc. compare | 10.2× |
| ABM ABM Industries Incorporated compare | 19.3× |
| AZZ AZZ Inc. compare | 21.9× |
| AMTM Amentum Holdings, Inc. compare | 25.6× |
| DLB Dolby Laboratories | 27.2× |
| ARMK Aramark compare | 34.5× |
| UNF Unifirst Corporation compare | 38.5× |
| RTO Rentokil Initial PLC compare | 70.5× |
| FA First Advantage Corporation compare | 92.5× |
| Specialty Business Services industry median | 24.5× |
| Industrials sector median | 23.3× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on DLB
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement